Exclusive: Germany OKs Northwest Bio brain cancer drug, shares soarReuters(Reuters) – Germany has granted Northwest Biotherapeutics Inc special permission to sell its experimental brain cancer drug in the country, the company said, and its stock jumped as much as 36 percent. The tiny U.S. biotech received a special “hospital …Healthcare Stocks Mixed in Afternoon Trade; Northwest Biometrics Jumps 13 …NASDAQEye Catching Stocks: Northwest Biotherapeutics, Inc (NWBO), Himax …Investor WiredNorthwest Biotherapeutics (NWBO) Receives ‘Very Strong’ Endorsement …StreetInsider.com (subscription)Motley Fool -FierceBiotechall 20 news articles …read more
Via: Google USA
Exclusive: Germany OKs Northwest Bio brain cancer drug, shares soar - Reuters
Real Estate of Cebu
